La cadena de opciones muestra datos clave de las opciones de acciones de Mogo a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Mogo..

Mogo (NASDAQ:MOGO) Bolsa, Cadena de Opciones

Mogo

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

Macro Economic Events

News

Econ #s

Economics

USA Factory Orders (MoM) For May 8.2% Vs 8.1% Est.

USA ISM Non-Manufacturing Prices For June 67.5 Vs 68.7 Prior

Macro Notification

General

USA ISM Non-Manufacturing PMI For June 50.8 Vs 50.8 Est.

UBS analyst Daniel Major maintains Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) with a Buy and raises the price target from $60 to $68.

Price Target

Analyst Ratings

UBS Maintains Buy on Newmont, Raises Price Target to $68

UBS analyst Daniel Major maintains Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) with a Buy and raises the price target from $205 to $210.

UBS Maintains Buy on Franco-Nevada, Raises Price Target to $210

UBS analyst Thomas Wadewitz maintains C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) with a Buy and lowers the price target from $130 to $129.

CHRW

UBS Maintains Buy on C.H. Robinson Worldwide, Lowers Price Target to $129

Truist Securities analyst David Smith maintains State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) with a Buy and raises the price target from $112 to $122.

Truist Securities Maintains Buy on State Street, Raises Price Target to $122

WIIM

LCID

Lucid shares are trading higher after the company reported Q2 production of 3,863 vehicles and deliveries of 3,309.

Truist Securities analyst David Smith maintains Northern Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) with a Hold and raises the price target from $116 to $126.

NTRS

Truist Securities Maintains Hold on Northern Trust, Raises Price Target to $126

UBS analyst Myles Allsop maintains Core Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>) with a Buy and lowers the price target from $80 to $78.

UBS Maintains Buy on Core Natural Resources, Lowers Price Target to $78

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Wolfe Research analyst Bill Carcache downgraded the rating for The PNC Financial Services Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) from Outperform to Peer Perform. PNC Financial shares closed at $195.70 on Wednesday. <a href="https://www.benzinga.com/quote/PNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jones Trading analyst Justin Walsh downgraded the rating for Theratechnologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THTX#NASDAQ">THTX</a>) from Buy to Hold. Theratechnologies shares closed at $2.36 on Wednesday. <a href="https://www.benzinga.com/quote/THTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Trevor Cranston downgraded Two Harbors Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWO#NYSE">TWO</a>) from Market Outperform to Market Perform. Two Harbors Investment shares closed at $10.65 on Wednesday. <a href="https://www.benzinga.com/quote/TWO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Tate Sullivan downgraded the rating for NV5 Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEE#NASDAQ">NVEE</a>) from Buy to Hold. NV5 Global shares closed at $23.22 on Wednesday. <a href="https://www.benzinga.com/quote/NVEE/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying PNC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/PNC/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="595" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094948/image-44-1024x595.png" alt="" class="wp-image-972162" style="width:509px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094948/image-44-1024x595.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094948/image-44-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094948/image-44-768x446.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094948/image-44.png 1127w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:<a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46218519/jim-cramer-gives-utilities-stock-a-week-says-doge-not-done-clobbering-booz-allen"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46218519/jim-cramer-gives-utilities-stock-a-week-says-doge-not-done-clobbering-booz-allen">Jim Cramer Gives Utilities Stock &#8216;A Week,&#8217; Says DOGE &#8216;Not Done Clobbering&#8217; Booz Allen</a> </li>
</ul>
Photo via Shutterstock

Downgrades

Markets

Trading Ideas

NVEE

THTX

This PNC Financial Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

UBS analyst Joshua Chan maintains UniFirst (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) with a Neutral and lowers the price target from $196 to $194.

UBS Maintains Neutral on UniFirst, Lowers Price Target to $194

Loop Capital analyst Jeffrey Stevenson maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Buy and lowers the price target from $21 to $20.

Loop Capital Maintains Buy on BrightView Hldgs, Lowers Price Target to $20

UBS analyst Peter Grom maintains Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Buy and raises the price target from $195 to $205.

UBS Maintains Buy on Constellation Brands, Raises Price Target to $205

S&P Global Composite PMI For June 52.9 Vs 52.8 Est.

S&P Global Services PMI For June 52.9 Vs 53.1 Est.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc analyst Tim Rezvan initiated coverage on Prairie Operating Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROP#NASDAQ">PROP</a>) with a Sector Weight rating. Prairie Operating shares closed at $3.44 on Wednesday. <a href="https://www.benzinga.com/quote/prop/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Robert Burns initiated coverage on Telix Pharmaceuticals Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLX#NASDAQ">TLX</a>) with a Buy rating and announced a price target of $23. Telix Pharmaceuticals shares closed at $16.42 on Wednesday. <a href="https://www.benzinga.com/quote/tlx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Janney Montgomery Scott analyst Sean Milligan initiated coverage on Primoris Services Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) with a Buy rating and announced a price target of $102. Primoris Services shares closed at $82.00 on Wednesday. <a href="https://www.benzinga.com/quote/prim/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst David Ridley-Lane initiated coverage on Ralliant Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAL#NYSE">RAL</a>) with an Underperform rating and announced a price target of $48. Ralliant shares closed at $45.77 on Wednesday. <a href="https://www.benzinga.com/quote/ral/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying PRIM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="574" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094158/image-43-1024x574.png" alt="" class="wp-image-972152" style="width:605px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094158/image-43-1024x574.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094158/image-43-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094158/image-43-768x430.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03094158/image-43.png 1137w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46218519/jim-cramer-gives-utilities-stock-a-week-says-doge-not-done-clobbering-booz-allen">Jim Cramer Gives Utilities Stock &#8216;A Week,&#8217; Says DOGE &#8216;Not Done Clobbering&#8217; Booz Allen</a> </li>
</ul>
Photo via Shutterstock

Initiation

PRIM

PROP

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

Citigroup analyst Ronald Josey maintains CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) with a Neutral and lowers the price target from $40 to $37.

CARG

Citigroup Maintains Neutral on CarGurus, Lowers Price Target to $37

<a href="https://truthsocial.com/@realDonaldTrump/114789577865630441">https://truthsocial.com/@realDonaldTrump/114789577865630441</a>

Politics

President Trump Posts On Truth Social "Will be speaking to President Putin of Russia at 10:00 A.M. Thank you!"

- Data from longer-term follow-up of patients in ongoing clinical trials further demonstrate durability of the clinical benefits of CASGEVY&#xAE; -
- Multiple reimbursement agreements secured, expanding access to CASGEVY to more patients around the world -
TORONTO, July 3, 2025 /CNW/ - <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4462066-1&amp;h=2284321717&amp;u=https%3A%2F%2Fwww.vrtx.ca%2F&amp;a=Vertex+Pharmaceuticals">Vertex Pharmaceuticals</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) recently announced positive longer-term data for PrCASGEVY&#xAE; (exagamglogene autotemcel) from global ongoing pivotal clinical trials in people&nbsp;with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, presented at the European Hematology Association (EHA) Congress,&nbsp;continue to demonstrate the durable clinical benefits of CASGEVY. The longest follow up in SCD patients now extends more than 5.5 years and in TDT patients more than 6 years, with a mean of 39.4 months and 43.5 months, respectively. CASGEVY is the first authorized CRISPR/Cas9 gene-edited therapy.

Biotech

VRTX

Vertex's CASGEVY Shows Over 5.5 Years Of Durable Benefit In Sickle Cell And Beta Thalassemia Trials Presented At The EHA Congress; Multiple Reimbursement Agreements Secured

Press Releases

Mogo to Announce Q4 2024 Financial Results March 20, 2025

Mogo Reports Results for Q4 & FY 2024

Mogo to Announce Q1 2025 Financial Results May 8, 2025

Mogo Reports Results for Q1 2025

Mogo to Participate in the D. Boral Capital Inaugural Global Conference

Mogo Portfolio Company WonderFi Announces Definitive Agreement to be Acquired by Robinhood Markets

Mogo Applies to Extend the Expiry Dates of Certain Warrants

Mogo Announces Results of its Annual General Meeting of Shareholders

Mogo Announces $50 Million Bitcoin Treasury Authorization and Strategic Alignment with Bitcoin Across the Organization

Synergy's (NASDAQ: SNYR) "FOCUSfactor" Massive 50,000 Store Expansion Including Walmart (NYSE: WMT) Canada – Alongside MOGO, ELWS, DAIC – Stocks Under $5 to Watch

Comments

Mogo

Mogo (MOGO) Opciones

Mogo (NASDAQ:MOGO) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL